Cyclobutanecarboxylic acid → HCID 86613885, compound
Reaction equation
[CH3:1][C:2]1[O:6][N:5]=[C:4]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)[C:3]=1[C:13]1[N:14]=[C:15]2[CH:20]=[CH:19][C:18]([NH2:21])=[CH:17][N:16]2[CH:22]=1.[CH:23]1([C:27](O)=[O:28])[CH2:26][CH2:25][CH2:24]1>>[CH3:1][C:2]1[O:6][N:5]=[C:4]([C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=2)[C:3]=1[C:13]1[N:14]=[C:15]2[CH:20]=[CH:19][C:18]([NH:21][C:27]([CH:23]3[CH2:26][CH2:25][CH2:24]3)=[O:28])=[CH:17][N:16]2[CH:22]=1Participants
3
Procedure
As described for Example 56, 2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridin-6-ylamine (96 mg, 0.33 mmol) was converted, using cyclobutanecarboxylic acid instead of cyclopropylacetic acid, to the title compound (33 mg, 30%) which was obtained as a light brown foam. MS: m/e=373.1 [M+H]+.
Sources & evidence
- ORD record
- ord-abe95320a9ce448ab951813046a02533
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07585874B2
Reaction notes
Loading…